Single answer
Is Addex Therapeutics Ltd (ADXN) a buy or sell?
4starter turns market data into one clear verdict you can act on.
Create a free account to save tickers and track your signals.
Log in to turn on watchlist alerts.
Decision snapshot
Everything you need to act fast, in one glance.
What is the conclusion?
Right now our advanced algorithms say:
Do analysts agree?
We compare consensus targets with today's price.
Consensus target for Addex Therapeutics Ltd is $30.00, which is $22.28 (288.60%) above the current price today's price.
Low target: $30.00 | High target: $30.00
Company snapshot
A quick overview of the business and its public profile.
Addex Therapeutics Ltd a developmentstage biopharmaceutical company discovers develops and commercializes smallmolecule pharmaceutical products for central nervous system CNS disorders in Switzerland The company focuses on the discovery of oral small molecule allosteric modulators of Gprotein coupled receptors Its lead programs include Dipraglurant for the treatment of Parkinsons disease levodopainduced dyskinesia and dystonia ADX71149 for epilepsy and undisclosed CNS disorders and GABAB PAM for addiction It has license and collaboration agreement with Janssen Pharmaceuticals Inc Indivior PLC and The CharcotMarieTooth Association The company was formerly known as Addex Pharmaceuticals Ltd and changed its name to Addex Therapeutics Ltd in March 2012 Addex Therapeutics Ltd was founded in 2002 and is headquartered in Geneva Switzerland
Website: https://www.addextherapeutics.com
Rates and inflation backdrop
US inflation for September 2025 was 0.31%. Over the last 12 months, inflation is 3.02%. The 10-year yield is 4.14 and is down -0.0800 over the last 30 days.
Inflation sensitivity
Debt ratio: 0.00. Cash flow to debt ratio: -43.10. Net profit margin: -9,018.29%. Inflation risk score: medium (0.70/1).
Dividend history check
We cannot find any recorded dividends paid in our systems.
Trading liquidity
No, the average daily trading liquidity for Addex Therapeutics Ltd is $197,696. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.
10-year return check
We cannot find data for Addex Therapeutics Ltd 10 years ago, but if you had invested on 2020-01-29 when the price was $14.50, you would have made a loss of $6.78 per share or 46.76%.
Why this answer
We combine price momentum, volatility, and trend signals to simplify the decision to one word.
Signal engine scans price, trend, and momentum indicators.
Targets and sentiment are checked against the live quote.
We keep the output simple: buy, sell, or hold.
Analyst consensus
How Wall Street targets compare to today's price.